Taysha Gene Therapies, Inc.
$3.62
-0.11 (-2.95%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -29.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -47.5%
Own TSHA?
See how TSHA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.